Page last updated: 2024-11-05

carbazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Carbazole is a tricyclic aromatic heterocyclic organic compound with the formula (C6H4)2NH. It is a white solid that is found in coal tar. Carbazole is a precursor to many useful products, including dyes, pharmaceuticals, and polymers. Carbazole has been shown to exhibit a variety of pharmacological activities, including antioxidant, anti-inflammatory, and anticancer effects. Carbazole is an important building block for the synthesis of organic light-emitting diodes (OLEDs) and other organic electronic materials. Carbazole is also a starting material for the synthesis of many other heterocyclic compounds. Carbazole is studied because of its potential applications in a variety of fields, including medicine, materials science, and organic chemistry.'

carbazole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6854
CHEMBL ID243580
CHEBI ID27543
SCHEMBL ID7650
SCHEMBL ID6026794
MeSH IDM0123117

Synonyms (75)

Synonym
smr000112232
MLS001066363
CHEBI:27543 ,
chlorophenesin carbamate
wln: t b656 hmj
dibenzopyrrole
diphenyleneimine
nsc3498
9-azafluorene
usaf ek-600
diphenylenimide
nsc-3498
dibenzo[b,d]pyrrole
diphenylenimine
inchi=1/c12h9n/c1-3-7-11-9(5-1)10-6-2-4-8-12(10)13-11/h1-8,13
NCGC00091233-01
hsdb 2164
einecs 201-696-0
dibenzo(b,d)pyrrole
ccris 121
skf 20091
nsc 3498
ai3-00096
86-74-8
9h-carbazole
carbazole
C08060
carbazole, >=95% (gc)
carbazole, analytical standard
NCGC00091233-02
MLS002415721
9h carbazole
DB07301
CHEMBL243580
BMSE000666
STK671343
AKOS000119129
A841825
NCGC00091233-03
cas-86-74-8
NCGC00256533-01
dtxcid40248
dtxsid4020248 ,
tox21_302847
tox21_201703
NCGC00259252-01
9ca ,
HMS2267P20
0p2197hhhn ,
ec 201-696-0
unii-0p2197hhhn
FT-0623455
PS-4072
carbazole [mi]
carbazole [hsdb]
carbazole [iarc]
SCHEMBL7650
9-h-carbazole
SCHEMBL6026794
Q-200795
STR04484
mfcd00004960
F0001-2148
carbazole, 96%
carbazole, vetranal(tm), analytical standard
AT24454
EN300-19085
carbazole, extra pure, 98%
Q424003
para-carbazole
carbazole 1000 microg/ml in methanol
51555-21-6
carbazole (high purity)
C3722
Z104472702

Research Excerpts

Overview

Carbazole is an essential building block in various pharmaceuticals, agrochemicals, natural products, and materials. Carbazole has a dioxin-like structure and possesses mutagenic and toxic activities.

ExcerptReferenceRelevance
"The carbazole scaffold is an active structure showing anti-cancer biological activity, and the structural diversity has been expanded through the improvement and optimization of synthesizing methods."( Design, synthesis, and evaluation of 9-(pyrimidin-2-yl)-9H-carbazole derivatives disrupting mitochondrial homeostasis in human lung adenocarcinoma.
Chen, YR; Li, KT; Ou, TM; Su, XX; Sun, JW; Wang, H; Wang, XN; Wu, JQ; Wu, XZ, 2022
)
1.45
"Carbazole is an essential building block in various pharmaceuticals, agrochemicals, natural products, and materials. "( Dearomatization-Rearomatization Strategy for Synthesizing Carbazoles with 2,2'-Biphenols and Ammonia by Dual C(Ar)-OH Bond Cleavages.
Cao, D; Li, CJ; Yu, J; Zeng, H, 2020
)
2.25
"9H-carbazole is an aromatic molecule that is tricyclic in nature, with two benzene rings fused onto a 5-membered pyrrole ring. "( Carbazole Scaffold in Medicinal Chemistry and Natural Products: A Review from 2010-2015.
Gündisch, D; Sun, D; Tsutsumi, LS, 2016
)
2.5
"Carbazole is a recalcitrant compound with a dioxin-like structure and possesses mutagenic and toxic activities. "( The genes coding for the conversion of carbazole to catechol are flanked by IS6100 elements in Sphingomonas sp. strain XLDN2-5.
Deng, Z; Gai, Z; He, X; Liu, X; Tai, C; Tang, H; Wang, X; Wu, G; Xu, P, 2010
)
2.07
"Carbazole is a promising pharmaceutical species. "( Carbazole as fluorescence carrier for preparation of doxycycline sensor.
Chen, LX; Huang, GH; Niu, CG; Shen, GL; Yu, RQ; Zeng, GM, 2003
)
3.2
"Carbazole is a nitrogen heterocyclic compound associated with fossil fuels and their products. "( Isolation and description of carbazole-degrading bacteria.
Aislabie, J; Hunter, DW; Shotbolt-Brown, J, 1996
)
2.03
"Carbazole (CA) is a heterocyclic nitrogen compound contained in the crude petroleum oil and recalcitrant to removal through the refinery processes. "( Recycle use of Sphingomonas sp. CDH-7 cells for continuous degradation of carbazole in the presence of MgCl2.
Kino, K; Kirimura, K; Kurane, R; Nakagawa, H; Nitta, T; Usami, S, 2002
)
1.99

Effects

Carbazole derivatives have been reported as a kind of fluorescent probe with many excellent optical properties. Lipocarbazole has been shown to be a powerful antioxidant in solution.

ExcerptReferenceRelevance
"Carbazole has a toxic influence on living organisms, and the knowledge of its persistence and bioconversion in ecosystems is still not complete."( Carbazole hydroxylation by the filamentous fungi of the Cunninghamella species.
Bernat, P; Felczak, A; Lisowska, K; Zawadzka, K, 2015
)
2.58
"Carbazole derivatives have been reported as a kind of fluorescent probe with many excellent optical properties."( A light-up probe targeting for Bcl-2 2345 G-quadruplex DNA with carbazole TO.
Fei, X; Gu, Y; Lin, D; Tang, Y; Wang, C; Zhang, B; Zhou, J, 2018
)
1.44
"Lipocarbazole has recently been shown to be a powerful antioxidant in solution."( Lipocarbazole, an efficient lipid peroxidation inhibitor anchored in the membrane.
Banala, S; Berka, K; Calliste, CA; Fabre, G; Hänchen, A; Otyepka, M; Süssmuth, RD; Trouillas, P, 2015
)
1.46
"Carbazole has a toxic influence on living organisms, and the knowledge of its persistence and bioconversion in ecosystems is still not complete."( Carbazole hydroxylation by the filamentous fungi of the Cunninghamella species.
Bernat, P; Felczak, A; Lisowska, K; Zawadzka, K, 2015
)
2.58

Actions

Carbazole skeleton plays a significant role as a structural scaffold of many pharmacologically active compounds. Carbazole was found to inhibit rac activation as a mechanism for its inhibition of downstream inflammatory and angiogenic pathways.

ExcerptReferenceRelevance
"Carbazole skeleton plays a significant role as a structural scaffold of many pharmacologically active compounds. "( Photosensitive and pH-dependent activity of pyrazine-functionalized carbazole derivative as promising antifungal and imaging agent.
Bagiński, M; Chylewska, A; Dąbrowska, AM; Maciejewska, N; Makowski, M; Olszewski, M; Ramotowska, S, 2020
)
2.24
"Carbazole was found to inhibit rac activation as a mechanism for its inhibition of downstream inflammatory and angiogenic pathways."( Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar.
Arbiser, JL; Battle, TE; Bowden, GT; Eissa, NT; Frank, DA; Govindarajan, B; Hossain, CF; Klein, E; Kolodziejski, PJ; Liu, A; Lynch, R; Nagle, DG; Perry, BN; Stern, DF; Ushio-Fukai, M, 2006
)
2.5

Treatment

ExcerptReferenceRelevance
"Carbazole treatment also reduced activity of inducible nitric oxide synthase (iNOS), which is proinflammatory and elevated in psoriasis."( Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar.
Arbiser, JL; Battle, TE; Bowden, GT; Eissa, NT; Frank, DA; Govindarajan, B; Hossain, CF; Klein, E; Kolodziejski, PJ; Liu, A; Lynch, R; Nagle, DG; Perry, BN; Stern, DF; Ushio-Fukai, M, 2006
)
2.5

Toxicity

ExcerptReferenceRelevance
"It is critical to develop highly effective antimicrobial agents that are not harmful to humans and do not present adverse effects on the environment."( Toxicity of a polymer-graphene oxide composite against bacterial planktonic cells, biofilms, and mammalian cells.
Mejías Carpio, IE; Rodrigues, DF; Santos, CM; Wei, X, 2012
)
0.38
" Dioxin-like toxicity did not decrease significantly with time, whereas the sum chlorocarbazole toxic equivalence concentrations (∑TEQ) did not contribute significantly to the soil assay dioxin-like toxicity equivalent concentrations (TCDD-EQ)."( Persistence and dioxin-like toxicity of carbazole and chlorocarbazoles in soil.
Abdelaziz, A; Henkelmann, B; Mumbo, J; Munch, JC; Nguyen, N; Pfister, G; Schramm, KW; Schroll, R, 2015
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
"The aim of this work was to evaluate the bioadhesive properties of non-hardened gliadin nanoparticles (NPs) and cross-linked gliadin nanoparticles (CL-NP) in the carbazole pharmacokinetic parameters obtained after the oral administration of these carriers."( Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics.
Arangoa, MA; Campanero, MA; Irache, JM; Ponchel, G; Renedo, MJ, 2001
)
0.51
" These pharmacokinetic modifications were directly related to the bioadhesive capacity of these carriers with the stomach mucosa."( Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics.
Arangoa, MA; Campanero, MA; Irache, JM; Ponchel, G; Renedo, MJ, 2001
)
0.31

Bioavailability

ExcerptReferenceRelevance
"Nanoparticles dramatically increased the carbazole oral bioavailability up to 49% and provided sustained release properties related to a decrease of the carbazole plasma elimination rate."( Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics.
Arangoa, MA; Campanero, MA; Irache, JM; Ponchel, G; Renedo, MJ, 2001
)
0.58
" In addition to the results obtained using 3 T3 NRU PT, further testing on 3D skin models may better reflect the bioavailability of a given chemical in the skin."( Evaluation of phototoxicity of tattoo pigments using the 3 T3 neutral red uptake phototoxicity test and a 3D human reconstructed skin model.
Choi, KH; Kim, SY; Seo, S; Yun, J, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbazole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
carbazole degradation611

Protein Targets (24)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency32.46480.025120.237639.8107AID886; AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency32.46480.025120.237639.8107AID886; AID893
LuciferasePhotinus pyralis (common eastern firefly)Potency39.23210.007215.758889.3584AID1224835
ClpPBacillus subtilisPotency35.48131.995322.673039.8107AID651965
RAR-related orphan receptor gammaMus musculus (house mouse)Potency21.44030.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency24.16210.000221.22318,912.5098AID1259243; AID1259247; AID588515; AID743036
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency35.03910.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency28.73620.000417.946075.1148AID1346795
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency30.91490.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency61.12710.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency54.42510.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency41.70330.000229.305416,493.5996AID1259244; AID743069
aryl hydrocarbon receptorHomo sapiens (human)Potency38.45310.000723.06741,258.9301AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency6.85900.001723.839378.1014AID743083
Histone H2A.xCricetulus griseus (Chinese hamster)Potency98.99900.039147.5451146.8240AID1224845
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency7.07953.548119.542744.6684AID743266
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.61130.000323.4451159.6830AID743065
histone deacetylase 9 isoform 3Homo sapiens (human)Potency53.54210.037617.082361.1927AID1259364
heat shock protein beta-1Homo sapiens (human)Potency61.64480.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.58960.000627.21521,122.0200AID720636
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency53.54210.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency53.54210.001551.739315,848.9004AID1259244
Nuclear receptor ROR-gammaHomo sapiens (human)Potency26.60320.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (49)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1827138Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID293662Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 9.26 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID293640Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 15.4 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID727886Inhibition of mushroom tyrosinase using L-DOPA as substrate after at 100 uM after 5 mins relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID318337Cytotoxicity against mock-infected MDBK cells by LDH method2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Gamma-carboline derivatives with anti-bovine viral diarrhea virus (BVDV) activity.
AID1827215Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus COL assessed as oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID293637Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 6.17 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID727892Cytotoxicity against mouse theophylline-induced B16-4A5 cells assessed as cell viability at 30 uM after 72 hrs by WST8 assay relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID727901Inhibition of theophylline-induced melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs by spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID727899Inhibition of theophylline-induced melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs by spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID1827210Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus COL assessed as fold change in oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID727894Cytotoxicity against mouse theophylline-induced B16-4A5 cells assessed as cell viability at 1 uM after 72 hrs by WST8 assay relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID727890Inhibition of mushroom tyrosinase using L-DOPA as substrate after at 1 uM after 5 mins relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID1827143Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as fold change in oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID1827233Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as fold change in oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID727902Inhibition of theophylline-induced melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs by spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID293638Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 9.26 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID727887Inhibition of mushroom tyrosinase using L-DOPA as substrate after at 30 uM after 5 mins relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID727898Inhibition of theophylline-induced melanogenesis in mouse B16-4A5 cells after 72 hrs by spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID1827142Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID318336Antiviral activity against BVDV infected in MDBK cells assessed as reduction in viral induced cell destruction by MTT assay2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Gamma-carboline derivatives with anti-bovine viral diarrhea virus (BVDV) activity.
AID293663Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 12.3 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID491351Inhibition of human C-terminally His6-tagged microtubule-activated KSP motor domain ATPase activity at 20 uM after 30 mins by luciferase-derived luminescence assay2010Journal of medicinal chemistry, Jul-08, Volume: 53, Issue:13
Kinesin spindle protein (KSP) inhibitors with 2,3-fused indole scaffolds.
AID293641Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 20.6 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID727888Inhibition of mushroom tyrosinase using L-DOPA as substrate after at 10 uM after 5 mins relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID727893Cytotoxicity against mouse theophylline-induced B16-4A5 cells assessed as cell viability at 3 uM after 72 hrs by WST8 assay relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID1827149Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus USA 100 assessed as fold change in oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID293665Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 20.6 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID293639Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis time at 12.3 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID293661Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 6.17 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID727900Inhibition of theophylline-induced melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs by spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID1827238Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus USA300 assessed as oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID1827235Potentiation of oxacillin induced antibacterial activity against methicillin-resistant Staphylococcus aureus USA100 assessed as oxacillin MIC at 50 uM after 18 hrs by CLSI protocol based broth microdilution assay2022ACS medicinal chemistry letters, Mar-10, Volume: 13, Issue:3
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA.
AID727889Inhibition of mushroom tyrosinase using L-DOPA as substrate after at 3 uM after 5 mins relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID293664Inhibition of AAPH-induced hemolysis in human erythrocytes assessed as hemolysis inhibition time at 15.4 uM2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
Free-radical-scavenging effect of carbazole derivatives on AAPH-induced hemolysis of human erythrocytes.
AID727891Cytotoxicity against mouse theophylline-induced B16-4A5 cells assessed as cell viability at 10 uM after 72 hrs by WST8 assay relative to control2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Alkaloids from Sri Lankan curry-leaf (Murraya koenigii) display melanogenesis inhibitory activity: structures of karapinchamines A and B.
AID673777Cytotoxicity in UV-irradiated human U937 cells exposed to photosensitizer for 2 hrs before irradiation for 20 mins by WST-1 assay2012ACS medicinal chemistry letters, Apr-12, Volume: 3, Issue:4
Type 1 Phototherapeutic Agents. 2. Cancer Cell Viability and ESR Studies of Tricyclic Diarylamines.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (549)

TimeframeStudies, This Drug (%)All Drugs %
pre-199032 (5.83)18.7374
1990's17 (3.10)18.2507
2000's131 (23.86)29.6817
2010's318 (57.92)24.3611
2020's51 (9.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.47 (24.57)
Research Supply Index6.32 (2.92)
Research Growth Index5.32 (4.65)
Search Engine Demand Index94.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.18%)5.53%
Reviews19 (3.42%)6.00%
Case Studies1 (0.18%)4.05%
Observational0 (0.00%)0.25%
Other535 (96.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]